A Study of PCI-32765 (Ibrutinib) in Patients With Refractory Follicular Lymphoma
Clinical trial NCT01779791 · COMPLETED
Trial details
- NCT number
- NCT01779791
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-04-17
- Primary completion
- 2016-05-18
- Enrollment
- 110
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.